156 related articles for article (PubMed ID: 35366876)
1. Parthenolide leads to proteomic differences in thyroid cancer cells and promotes apoptosis.
Cui M; Wang Z; Huang LT; Wang JH
BMC Complement Med Ther; 2022 Apr; 22(1):99. PubMed ID: 35366876
[TBL] [Abstract][Full Text] [Related]
2. Parthenolide induces apoptosis via TNFRSF10B and PMAIP1 pathways in human lung cancer cells.
Zhao X; Liu X; Su L
J Exp Clin Cancer Res; 2014 Jan; 33(1):3. PubMed ID: 24387758
[TBL] [Abstract][Full Text] [Related]
3. Parthenolide inhibits tumor-promoting effects of nicotine in lung cancer by inducing P53 - dependent apoptosis and inhibiting VEGF expression.
Talib WH; Al Kury LT
Biomed Pharmacother; 2018 Nov; 107():1488-1495. PubMed ID: 30257366
[TBL] [Abstract][Full Text] [Related]
4. Parthenolide Induces Reactive Oxygen Species-Mediated Autophagic Cell Death in Human Osteosarcoma Cells.
Yang C; Yang QO; Kong QJ; Yuan W; Ou Yang YP
Cell Physiol Biochem; 2016; 40(1-2):146-154. PubMed ID: 27855364
[TBL] [Abstract][Full Text] [Related]
5. Effect of parthenolide on growth and apoptosis regulatory genes of human cancer cell lines.
Al-Fatlawi AA; Al-Fatlawi AA; Irshad M; Rahisuddin ; Ahmad A
Pharm Biol; 2015 Jan; 53(1):104-9. PubMed ID: 25289524
[TBL] [Abstract][Full Text] [Related]
6. Curcumin induces endoplasmic reticulum stress-associated apoptosis in human papillary thyroid carcinoma BCPAP cells via disruption of intracellular calcium homeostasis.
Zhang L; Cheng X; Xu S; Bao J; Yu H
Medicine (Baltimore); 2018 Jun; 97(24):e11095. PubMed ID: 29901626
[TBL] [Abstract][Full Text] [Related]
7. Parthenolide protects human lens epithelial cells from oxidative stress-induced apoptosis via inhibition of activation of caspase-3 and caspase-9.
Yao H; Tang X; Shao X; Feng L; Wu N; Yao K
Cell Res; 2007 Jun; 17(6):565-71. PubMed ID: 17339884
[TBL] [Abstract][Full Text] [Related]
8. Identification of the genes involved in enhanced fenretinide-induced apoptosis by parthenolide in human hepatoma cells.
Park JH; Liu L; Kim IH; Kim JH; You KR; Kim DG
Cancer Res; 2005 Apr; 65(7):2804-14. PubMed ID: 15805281
[TBL] [Abstract][Full Text] [Related]
9. Metabonomic study of the intervention effects of Parthenolide on anti-thyroid cancer activity.
Yuan L; Wang Z; Zhang D; Wang J
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Aug; 1150():122179. PubMed ID: 32506011
[TBL] [Abstract][Full Text] [Related]
10. Parthenolide induces proliferation inhibition and apoptosis of pancreatic cancer cells in vitro.
Liu JW; Cai MX; Xin Y; Wu QS; Ma J; Yang P; Xie HY; Huang DS
J Exp Clin Cancer Res; 2010 Aug; 29(1):108. PubMed ID: 20698986
[TBL] [Abstract][Full Text] [Related]
11. Cell context-dependent activities of parthenolide in primary and metastatic melanoma cells.
Czyz M; Lesiak-Mieczkowska K; Koprowska K; Szulawska-Mroczek A; Wozniak M
Br J Pharmacol; 2010 Jul; 160(5):1144-57. PubMed ID: 20590608
[TBL] [Abstract][Full Text] [Related]
12. Antitumor agent parthenolide reverses resistance of breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand through sustained activation of c-Jun N-terminal kinase.
Nakshatri H; Rice SE; Bhat-Nakshatri P
Oncogene; 2004 Sep; 23(44):7330-44. PubMed ID: 15286701
[TBL] [Abstract][Full Text] [Related]
13. Effect of parthenolide on proliferation and apoptosis in gastric cancer cell line SGC7901.
Zhao LJ; Xu YH; Li Y
J Dig Dis; 2009 Aug; 10(3):172-80. PubMed ID: 19659784
[TBL] [Abstract][Full Text] [Related]
14. Parthenolide-induced apoptosis, autophagy and suppression of proliferation in HepG2 cells.
Sun J; Zhang C; Bao YL; Wu Y; Chen ZL; Yu CL; Huang YX; Sun Y; Zheng LH; Wang X; Li YX
Asian Pac J Cancer Prev; 2014; 15(12):4897-902. PubMed ID: 24998560
[TBL] [Abstract][Full Text] [Related]
15. Parthenolide sensitizes hepatocellular carcinoma cells to TRAIL by inducing the expression of death receptors through inhibition of STAT3 activation.
Carlisi D; D'Anneo A; Angileri L; Lauricella M; Emanuele S; Santulli A; Vento R; Tesoriere G
J Cell Physiol; 2011 Jun; 226(6):1632-41. PubMed ID: 21413021
[TBL] [Abstract][Full Text] [Related]
16. Parthenolide reduces metastasis by inhibition of vimentin expression and induces apoptosis by suppression elongation factor α - 1 expression.
Jafari N; Nazeri S; Enferadi ST
Phytomedicine; 2018 Mar; 41():67-73. PubMed ID: 29519321
[TBL] [Abstract][Full Text] [Related]
17. Proteomic identification of differentially expressed proteins in curcumin-treated MCF-7 cells.
Fang HY; Chen SB; Guo DJ; Pan SY; Yu ZL
Phytomedicine; 2011 Jun; 18(8-9):697-703. PubMed ID: 21239154
[TBL] [Abstract][Full Text] [Related]
18. Critical roles of intracellular thiols and calcium in parthenolide-induced apoptosis in human colorectal cancer cells.
Zhang S; Ong CN; Shen HM
Cancer Lett; 2004 May; 208(2):143-53. PubMed ID: 15142672
[TBL] [Abstract][Full Text] [Related]
19. Parthenolide induces apoptosis and autophagy through the suppression of PI3K/Akt signaling pathway in cervical cancer.
Jeyamohan S; Moorthy RK; Kannan MK; Arockiam AJ
Biotechnol Lett; 2016 Aug; 38(8):1251-60. PubMed ID: 27099069
[TBL] [Abstract][Full Text] [Related]
20. The MEK1/2 Inhibitor AZD6244 Sensitizes BRAF-Mutant Thyroid Cancer to Vemurafenib.
Song H; Zhang J; Ning L; Zhang H; Chen D; Jiao X; Zhang K
Med Sci Monit; 2018 May; 24():3002-3010. PubMed ID: 29737325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
